Dead bands between a type of diabetes drug and a life-threatening meat-eating infection have been shown in a recent report by U.S. Pat. Food and Drug Administration.
The study, published in the Annals of Internal Medicine, found links between a genital infection called the Fournier gangrene and a class of prescription drugs used for people with type 2 diabetes called sodium-glucose co-transporter-2 inhibitors.
The FDA identified 55 cases of FG in patients receiving SGLT2 inhibitors between March 2013 and January 2019, with patients aged 22 to 87 years.
In 2017, about 1.7 million people received a prescription for diabetes medication from retail pharmacies.
Of all patients examined in the study:
* All had surgically damaged tissue removed
* Eight undergone faecal redirection surgery
* Two required amputation due to meat eat bacteria
* Three dead
According to the FDA, SGLT2 inhibitors FDA is approved for use with diet and exercise to lower blood sugar in adults with type 2 diabetes.
The FDA issued a warning last year linking the extremely rare and life-threatening bacterial infection to SGLT2 inhibitors, which said between March 2013 and May 2018, 12 cases of infection were found.
All 12 cases required hospitalization and surgery. One resulted in death.
With the increase in cases, the FDA says that FG is still a newly identified safety issue in patients receiving SGLT2 inhibitors.
The study warns that doctors prescribing the drug should pay close attention to the possible complication of the treatment and maintain a "high index of suspicion to recognize it in its early stages."
This story was reported from Los Angeles